ENERCA will pioneer the design of e-Health tools in rare anaemias for patients and experts
The European Network for Rare and Congenital Anaemias (ENERCA) is a project funded by the European Commission through the Executive Agency for Health1
The European Network for Rare and Congenital Anaemias (ENERCA) is a project funded by the European Commission through the Executive Agency for Health1
After the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD), which brought 20,000 diabetologists to Barcelona until Se1
Marc Claret, researcher at the IDIBAPS Laboratory of Diabetes and Obesity, Ramon Gomis, director of IDIBAPS, and Enric Banda, director of the Depart1
More than 500 research studies outlining the latest advances and obstacles in the search for an AIDS vaccine will be presented and debated at AIDS Va1
Research conducted entirely in Barcelona has discovered that fetuses conceived by assisted reproduction (AR) present changes in their heart and arter1
About 20,000 diabetologists will attend the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD), to be held in Barcelona1
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare, progressive and life-threatening disease. The Hospital Clínic of Barcelona is a refe1
Dr. Josep Dalmau is an ICREA investigator leading the IDIBAPS Autoimmunity against synaptic antigens Group. His international impact is reflected in1
Early treatment of asymptomatic high-risk smoldering myeloma could significantly improve the course of disease, slowing its progression and significa1